12/26
01:51 pm
teva
This International Pharma Stock Just Hit 5-Year Highs [Yahoo! Finance]
Low
Report
This International Pharma Stock Just Hit 5-Year Highs [Yahoo! Finance]
12/24
04:31 pm
teva
S&P Global Ratings Upgrades Teva to ‘BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive [Yahoo! Finance]
Low
Report
S&P Global Ratings Upgrades Teva to ‘BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive [Yahoo! Finance]
12/24
08:36 am
teva
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
Low
Report
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
12/22
08:02 am
teva
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Piper Sandler from $30.00 to $40.00. They now have an "overweight" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Piper Sandler from $30.00 to $40.00. They now have an "overweight" rating on the stock.
12/21
09:10 am
teva
Teva Pharmaceutical Industries' (NYSE:TEVA) investors will be pleased with their impressive 228% return over the last three years [Yahoo! Finance]
Low
Report
Teva Pharmaceutical Industries' (NYSE:TEVA) investors will be pleased with their impressive 228% return over the last three years [Yahoo! Finance]
12/19
12:22 pm
teva
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $31.00 to $35.00. They now have a "buy" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $31.00 to $35.00. They now have a "buy" rating on the stock.
12/19
03:40 am
teva
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
Low
Report
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
12/16
11:08 am
teva
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at JPMorgan Chase & Co. from $28.00 to $35.00. They now have an "overweight" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at JPMorgan Chase & Co. from $28.00 to $35.00. They now have an "overweight" rating on the stock.
12/14
03:58 pm
teva
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? [Yahoo! Finance]
Low
Report
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? [Yahoo! Finance]
12/14
03:09 am
teva
Will Teva's (TEVA) Extended Sustainability-Linked Credit Line Reshape Its Balance Sheet and Risk Narrative? [Yahoo! Finance]
Low
Report
Will Teva's (TEVA) Extended Sustainability-Linked Credit Line Reshape Its Balance Sheet and Risk Narrative? [Yahoo! Finance]
12/13
01:10 am
teva
12/12
05:32 pm
teva
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026 [Yahoo! Finance]
Low
Report
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026 [Yahoo! Finance]
12/12
04:44 pm
teva
Teva Releases Q4 2025 Aide Memoire [Yahoo! Finance]
Low
Report
Teva Releases Q4 2025 Aide Memoire [Yahoo! Finance]
12/12
04:30 pm
teva
Teva Releases Q4 2025 Aide Memoire
Low
Report
Teva Releases Q4 2025 Aide Memoire
12/12
04:30 pm
teva
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Low
Report
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
12/10
07:18 am
teva
Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
12/9
01:15 pm
teva
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Bank of America Corporation from $29.00 to $32.00. They now have a "buy" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Bank of America Corporation from $29.00 to $32.00. They now have a "buy" rating on the stock.
12/9
09:06 am
teva
Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $35.00 price target on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $35.00 price target on the stock.
12/9
08:00 am
teva
Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Low
Report
Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
12/8
11:41 am
teva
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $28.00 to $31.00. They now have a "buy" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $28.00 to $31.00. They now have a "buy" rating on the stock.
12/5
09:11 am
teva
Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.
12/2
11:47 am
teva
Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term [Yahoo! Finance]
11/30
09:05 am
teva
Why Hall Of Famer Terrell Davis Is Talking About The ‘Other TD' [Forbes]
Low
Report
Why Hall Of Famer Terrell Davis Is Talking About The ‘Other TD' [Forbes]
11/30
07:34 am
teva
With 72% ownership in Teva Pharmaceutical Industries Limited (NYSE:TEVA), institutional investors have a lot riding on the business [Yahoo! Finance]
Low
Report
With 72% ownership in Teva Pharmaceutical Industries Limited (NYSE:TEVA), institutional investors have a lot riding on the business [Yahoo! Finance]
11/26
12:30 am
teva
Is Teva a Bargain After 27% Surge and Cost-Cutting Headlines? [Yahoo! Finance]
Medium
Report
Is Teva a Bargain After 27% Surge and Cost-Cutting Headlines? [Yahoo! Finance]